These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35285539)

  • 1. Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolism.
    Jeon HY; Choi J; Kraaier L; Kim YH; Eisenbarth D; Yi K; Kang JG; Kim JW; Shim HS; Lee JH; Lim DS
    EMBO J; 2022 Apr; 41(8):e109365. PubMed ID: 35285539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis.
    Warren R; Lyu H; Klinkhammer K; De Langhe SP
    Elife; 2023 May; 12():. PubMed ID: 37166104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury.
    DiGiovanni GT; Han W; Sherrill TP; Taylor CJ; Nichols DS; Geis NM; Singha UK; Calvi CL; McCall AS; Dixon MM; Liu Y; Jang JH; Gutor SS; Polosukhin VV; Blackwell TS; Kropski JA; Gokey JJ
    JCI Insight; 2023 Sep; 8(19):. PubMed ID: 37676731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis.
    Hicks-Berthet J; Ning B; Federico A; Tilston-Lunel A; Matschulat A; Ai X; Lenburg ME; Beane J; Monti S; Varelas X
    Cell Rep; 2021 Jul; 36(2):109347. PubMed ID: 34260916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
    Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
    Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex.
    Terry BK; Park R; Cho SH; Crino PB; Kim S
    Hum Mol Genet; 2022 Jun; 31(12):1979-1996. PubMed ID: 34999833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
    Lin C; Yao E; Chuang PT
    Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth.
    Ong YT; Andrade J; Armbruster M; Shi C; Castro M; Costa ASH; Sugino T; Eelen G; Zimmermann B; Wilhelm K; Lim J; Watanabe S; Guenther S; Schneider A; Zanconato F; Kaulich M; Pan D; Braun T; Gerhardt H; Efeyan A; Carmeliet P; Piccolo S; Grosso AR; Potente M
    Nat Metab; 2022 Jun; 4(6):672-682. PubMed ID: 35726026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.
    Lu X; Peng B; Chen G; Pes MG; Ribback S; Ament C; Xu H; Pal R; Rodrigues PM; Banales JM; Evert M; Calvisi DF; Chen X; Fan B; Wang J
    Am J Pathol; 2021 Sep; 191(9):1651-1667. PubMed ID: 34129844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.
    Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS
    Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stretch increases alveolar type 1 cell number in fetal lungs through ROCK-Yap/Taz pathway.
    Nguyen TM; van der Merwe J; Elowsson Rendin L; Larsson-Callerfelt AK; Deprest J; Westergren-Thorsson G; Toelen J
    Am J Physiol Lung Cell Mol Physiol; 2021 Nov; 321(5):L814-L826. PubMed ID: 34431413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential chromatin binding of the lung lineage transcription factor NKX2-1 resolves opposing murine alveolar cell fates in vivo.
    Little DR; Lynch AM; Yan Y; Akiyama H; Kimura S; Chen J
    Nat Commun; 2021 May; 12(1):2509. PubMed ID: 33947861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate.
    Totaro A; Castellan M; Battilana G; Zanconato F; Azzolin L; Giulitti S; Cordenonsi M; Piccolo S
    Nat Commun; 2017 May; 8():15206. PubMed ID: 28513598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Hippo/YAP Signaling in Alveolar Repair and Pulmonary Fibrosis.
    Gokey JJ; Patel SD; Kropski JA
    Front Med (Lausanne); 2021; 8():752316. PubMed ID: 34671628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
    Budel SJ; Penning MM; Penning LC
    Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell sequencing reveals the antifibrotic effects of YAP/TAZ in systemic sclerosis.
    Wu D; Wang W; Li X; Yin B; Ma Y
    Int J Biochem Cell Biol; 2022 Aug; 149():106257. PubMed ID: 35772663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.